VRDN (STOCKS)
Viridian Therapeutics, Inc. Common Stock
$30.300000
+0.240000 (+0.80%)
Prev close: $30.060000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Stephen Frank Mahoney
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $2,971.98M
- Employees
- 143
- P/E (TTM)
- -8.51
- P/B (TTM)
- 7.87
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
9
Strong Buy
13
Buy
3
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-0.34 | $-1.10 | +0.7644 | +69.21% |
|
Jun 2025 (Q2)
|
$-1.00 | $-1.03 | +0.0296 | +2.87% |
|
Mar 2025 (Q1)
|
$-0.87 | $-0.99 | +0.1164 | +11.80% |
|
Dec 2024 (Q4)
|
$-1.00 | $-1.06 | +0.0560 | +5.30% |